Influence of bile on the absorption of halofantrine from lipid-based formulations

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 81, Issue 2, 2012, Pages 281-287

  Holm, René ^a   Tonsberg, Henrik ^a,b   Jorgensen, Erling B ^a   Abedinpour, Puyan ^a,b   Farsad, Shafiq ^a,b   Müllertz, Anette ^b  

^a H LUNDBECK A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Bile; Bile duct cannulated rats; Intestinal absorption; Poorly water soluble drugs; SNEEDS

Indexed keywords

HALOFANTRINE; LIPID; SOYBEAN OIL;

ANIMAL EXPERIMENT; ARTICLE; BILE; BILE DUCT; CANNULATION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; INTESTINE ABSORPTION; MALE; NONHUMAN; RAT; SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM;

ANIMALS; BILE; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; INTESTINAL ABSORPTION; LIPIDS; MALE; OILS; PARTICLE SIZE; PHENANTHRENES; RATS; RATS, SPRAGUE-DAWLEY; SOYBEAN OIL;

EID: 84861608465     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.03.005     Document Type: Article

References (54)

1. A. Fahr, and X. Liu Drug delivery strategies for poorly water-soluble drugs Exp. Opin. Drug Deliv. 4 2007 403 416
2. D.J. Hauss Oral lipid-based formulations Adv. Drug Deliv. Rev. 59 2007 667 676
3. P.P. Constantinides Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects Pharm. Res. 12 1995 1561 1572
4. W.N. Charman, M.C. Rogge, A.W. Boddy, and B.M. Berger Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound Pharm. Res. 9 1992 87 93
5. C.W. Pouton Formulation of self-emulsifying drug delivery systems Adv. Drug Deliv. Rev. 25 1997 47 58
6. N.H. Shah, M.T. Carvajal, C.I. Patel, M.H. Infeld, and A.W. Malick Self-emulsifying drug-delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs Int. J. Pharm. 106 1994 15 23
7. F.S. Nielsen, E. Gibault, H. Ljusberg-Wahren, J.S.P. Arleth, and A. Müllertz Characterization of prototype self-nanoemulsifying formulation of lipophilic compound J. Pharm. Sci. 96 2006 876 892
8. C.J.H. Porter, C.W. Pourton, F.J. Cuine, and W.N. Charman Enhancing intestinal drug solubilisation using lipid-based delivery systems Adv. Drug Deliv. Rev. 60 2008 673 691
9. C.W. Pouton Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system Eur. J. Pharm. Sci. 29 2006 278 287
10. M. Kuentz Oral self-emulsifying drug delivery systems, from biopharmaceutical to technical formulation aspects J. Drug Deliv. Technol. 21 2011 17 26
11. K. Kohli, S. Chopra, D. Dhar, S. Arora, and R.K. Khar Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability Drug Discov. Today 15 2010 958 965
12. A. Müllertz, A. Ogbonna, S. Ren, and T. Rades New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs J. Pharm. Pharmacol. 62 2010 1622 1636
13. B. Singh, S. Bandopadhyay, R. Kapil, R. Singh, and O.P. Katare Self-emulsifying drug delivery systems (SEDDS): Formulation development, characterization, and applications Crit. Rev. Ther. Drug 26 2009 427 521
14. C.J.H. Porter, N.L. Trevaskis, and W.N. Charman Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs Nat. Rev. Drug Discov. 6 2007 231 248
15. A.F. Hofmann, and L.R. Hagey Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics Cell. Mol. Life Sci. 65 2008 2461 2483
16. E.A. Mueller, J.M. Kovarik, J.B. van Bree, J. Grevel, P.W. Lücker, and K. Kutz Influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine in a crossover comparison with the market formulation Pharm. Res. 11 1994 151 155
17. K. Kleberg, J. Jacobsen, and A. Müllertz Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies J. Pharm. Pharmacol. 62 2010 1656 1668
18. G. Levy, J. Rochon, D. Freeman, P.Y. Wong, L. Banks, C. Roach, K. Engel, and D. Grant Cyclosporin neoral in liver transplant recipients Transplant. Proc. 26 1994 2949 2952
19. H. Araya, M. Tomita, and M. Hayashi The novel formulation design of self-emulsifying drug delivery systems (SEDDS) type o/w microemulsion II: stable gastrointestinal absorption of a poor water soluble new compound, ER-1258 in bile-fistula rats Drug Metab. Pharmacokinet. 20 2005 257 267
20. H. Tonsberg, R. Holm, T.G. Bjerregaard, J.B. Boll, J. Jacobsen, and A. Müllertz An updated and simplified method for bile duct cannulation of rats Lab. Anim. 44 2010 373 376
21. H. Tonsberg, R. Holm, J.B. Boll, J. Jacobsen, and A. Müllertz Effects of polysorbate 80 on the in vitro precipitation and oral bioavailability of halofantrine from polyethylene glycol 400 formulations in rats J. Pharm. Pharmacol. 62 2010 63 70
22. A.J. Humberstone, G.J. Currie, C.J.H. Porter, M.J. Scanlon, and W.N. Charman A simplified liquid chromatography assay for the quantitation of halofantrine and desbutylhalofantrine in plasma and identification of a degradation product of desbutylhalofantrine formed under alkaline conditions J. Pharm. Biomed. Anal. 13 1995 265 272
23. R. Holm, E.B. Jorgensen, M. Harborg, R. Larsen, P. Holm, A. Müllertz, and J. Jacobsen A novel excipient, 1-perfluorohexyloctane shows limited utility for the oral delivery of poorly water-soluble drugs Eur. J. Pharm. Sci. 42 2011 416 422
24. H. Tonsberg, R. Holm, H. Mu, J.B. Boll, J. Jacobsen, and A. Müllertz Effect of bile on the oral absorption of halofantrine dosed to bile duct cannulated rats in polyethylene glycol 400 and polysorbate 80 formulations J. Pharm. Pharmacol. 63 2011 817 824
25. D.M. Karpf, R. Holm, H.G. Kristensen, and A. Müllertz Influence of the type of surfactant and the degree of dispersion on the lymphatic transport of halofantrine in conscious rats Pharm. Res. 21 2004 1413 1418
26. M.L. Lind, J. Jacobsen, R. Holm, and A. Müllertz Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80 Eur. J. Pharm. Sci. 35 2008 211 218
27. W.N. Charman Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts J. Pharm. Sci. 89 2000 967 978
28. A.K. Trull, T.L. Tan, G.J.M. Alexander, and N.V. Jamieson Enhanced absorption of new oral cyclosporin microemulsion formulation, Neoral, in liver transplant recipients with external biliary diversion Transplant. Proc. 26 1994 2977 2978
29. S.M. Caliph, W.N. Charman, and C.J.H. Porter Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats J. Pharm. Sci. 89 2000 1073 1084
30. R. Holm, C.J.H. Porter, A. Müllertz, H.G. Kristensen, and W.N. Charman Structured triglyceride vehicles for oral delivery of halofantrine: examination of intestinal lymphatic transport and bioavailability in conscious rats Pharm. Res. 19 2002 1354 1361
31. P.C. de Smidt, M.A. Campanero, and I.F. Trocóniz Intestinal absorption of penclomedine from lipid vehicles in the conscious rat: contribution of emulsification versus digestibility Int. J. Pharm. 270 2004 109 118
32. K. Iwanaga, T. Kushibiki, M. Miyzaki, and M. Kakemi Disposition of lipid-based formulation in the intestinal tract affects the absorption of poorly water-soluble drugs Biol. Pharm. Bull. 29 2006 508 512
33. N. Balandraud-Pieri, P.-E. Queneau, F.-X. Caroli-Bosc, P. Bertault-Pérès, A.-M. Montet, A. Durand, and J.C. Montet Effects of tauroursodeoxycholate solutions on cyclosporin A bioavailability in rats Drug Metab. Disp. 25 1997 912 916
34. H. Araya, S. Nagao, M. Tomita, and M. Hayashi The novel formulation design of self-emulsifying drug delivery systems (SEDDS) typo O/W microemulsion I: enhancing effects on oral bioavailability of poorly water soluble compounds in rats and beagle dogs Drug Metab. Pharmacokinet. 20 2005 244 256
35. D.W. Holt, E.A. Mueller, J.M. Kovarik, J.B. van Bree, and K. Kutz The pharmacokinetics of sandimmun neoral: a new oral formulation of cyclosporine Transplant. Proc. 26 1994 2935 2939
36. H.U. Meier-Kriesche, R. Swinford, B.D. Kahan, P. Brannan, and R.J. Portman Reduced variability of neoral pharmacokinetic studies in pediatric transplantation Pediatr. Nephrol. 15 2000 2 6
37. H.U. Meier-Kriesche, R. Swinford, B.D. Kahan, P. Brannan, and R.J. Portman Reduced variability of neoral pharmacokinetic studies in pediatric renal transplantation Pediatr. Nephrol. 16 2001 303 309
38. F.S. Nielsen, K.B. Petersen, and A. Müllertz Bioavailability of probucol from lipid and surfactant based formulation in minipigs: influence of droplet size and dietary state Eur. J. Pharm. Biopharm. 69 2008 553 562
39. H. Toguchi, Y. Ogawa, K. Iga, T. Yashiki, and T. Shimamoto Gastro-intestinal absorption of ethyl 2-chloro-3-[4-(2-methyl-phenylpropyloxy) phenyl]propionate from different dosage forms in rats and dogs Chem. Pharm. Bull. 38 1990 2792 2796
40. H. Toguchi, Y. Ogawa, and T. Shimamoto Effect of the physiochemical properties of the emulsion formation on the bioavailability of ethyl 2-chloro-3-[4-(2-methyl-2-phenylpropyloxy)phenyl]propionate in rats Chem. Pharm. Bull. 38 1990 2797 2800
41. C.J.H. Porter, A.M. Kaukonen, B.J. Boyd, G.A. Edwards, and W.N. Charman Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation Pharm. Res. 21 2004 1405 1412
42. A.J. Humberstone, and W.N. Charman Lipid-based vehicle for the oral delivery of poorly water soluble drugs Adv. Drug Deliv. Rev. 25 1997 103 128
43. A. Christiansen, T. Backensfeld, K. Denner, and W. Weitschies Effects of non-ionic surfactants on cytochrome P450-mediated metabolism in vitro Eur. J. Pharm. Biopharm. 78 2011 166 172
44. R.C.B. Gonzalez, J. Huwyler, F. Boess, I. Walter, and B. Bittner In vitro investigation on the impact of the surface-active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam Biopharm. Drug Dispos. 25 2004 37 49
45. X. Ren, X. Mao, L. Si, L. Cao, H. Xiong, J. Qiu, A.D. Schimmer, and G. Li Pharmaceutical excipients inhibit cytochrome P450 activity in cell free systems and after systemic administration Eur. J. Pharm. Biopharm. 70 2008 279 288
46. B. Charbit, L. Becquemont, B. Lepère, G. Peytavin, and C. Funck-Brentano Pharmacokinetic and pharmacodynamic interaction between grapefruit juice and halofantrine Clin. Pharmacol. Ther. 72 2002 514 523
47. C.J.H. Porter, S. A Charman, and W.N. Charman Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion J. Pharm. Sci. 85 1996 351 356
48. W.N. Charman, and V.J. Stella Estimating the maximal potential for intestinal lymphatic transport of lipophilic drug molecules Int. J. Pharm. 34 1986 175 178
49. W.N. Charman, and V.J. Stella Effect of lipid class and lipid vehicle volume on the intestinal lymphatic transport of DDT Int. J. Pharm. 33 1986 165 172
50. J.M. Laher, M.W. Rigler, R.D. Vetter, J.A. Barrowman, and J.S. Patton Similar bioavailability and lymphatic transport of benzo(a)pyrene when administered to rats in different amounts of dietary fat J. Lipid Res. 25 1984 1337 1342
51. R. Holm, A. Müllertz, E. Christensen, C.-E. Hoy, and H.G. Kristensen Comparison of total oral bioavailability and the lymphatic transport of halofantrine from three different unsaturated triglycerides in lymph-cannulated conscious rats Eur. J. Pharm. Sci. 14 2001 331 337
52. C.T. Ueda, M. Lemaire, G. Gsell, and K. Nussbaumer Intestinal lymphatic absorption of cyclosporin A following oral administration in an olive oil solution in rats Biopharm. Drug Dispos. 4 1983 113 124
53. N.L. Trevaskis, C.J.H. Porter, and W.N. Charman Bile increases intestinal lymphatic drug transport in the fasted rat Pharm. Res. 22 2005 1863 1870
54. J.K. Embleton, and C.W. Pouton Structure and function of gastro-intestinal lipases Adv. Drug Deliv. Rev. 25 1997 15 32